SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for GSK (GSK) — Jun 23, 2015

GSK plc
Date: June 23, 2015 · CIK: 0001131399 · Accession: 0000000000-15-032978

AI Filing Summary & Sentiment

Date
June 23, 2015
Author
/s/ Sharon M. Blume
Form
UPLOAD
Company
GSK plc

Letter

June 23, 2015 Via E -mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom

Re: GlaxoSmithKline plc Form 20-F for the Fiscal Year Ended December 31 , 2014 Filed February 27, 2015 File No. 1-15170

Dear Mr. Dingemans :

We have completed our review of your filing. We remind you that our comments or changes to disclosu re in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the compa ny may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities la ws of the United States . We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Sharon M. Blume

Show Raw Text
June 23, 2015

Via E -mail
Mr. Simon Dingemans
Chief Financial  Officer
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom

Re: GlaxoSmithKline plc
 Form 20-F for the Fiscal Year Ended December 31 , 2014
Filed February 27, 2015
 File No. 1-15170

Dear Mr. Dingemans :

We have completed our review of your filing.  We remind you that our comments  or
changes to disclosu re in response to our comments  do not foreclose the Commission from taking
any action with respect to the company or the filing  and the compa ny may not assert staff
comments  as a defense in any proceeding initiated by the Commission or any person under the
federal securities la ws of the United States .  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

        /s/ Sharon M. Blume

Sharon M. Blume
Accounting Branch Chief